-+ 0.00%
-+ 0.00%
-+ 0.00%

Pyxis Oncology Inc. Announces Revisions to Patient Enrollment in Phase 1 Clinical Trial for Micvotabart Pelidotin (MICVO)

Reuters·08/04/2025 11:27:05

Please log in to view news